A prospective, observational study investigating safety and efficacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir with or without ribavirin in chronic Hepatitis C patients with genotype 1 and 4 infection: a real life study.
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Jul 2017 New trial record